AAP
TNGX icon

Arax Advisory Partners’s Tango Therapeutics TNGX Stock Holding History

Arax Advisory Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.1K Buy
+1,218
New +$30.1K ﹤0.01% 3495
2026
Q1 		– Sell
-8
Closed -$71 – 4321
2025
Q4 		$71 Sell
8
-1,194
-99% -$10.3K ﹤0.01% 3878
2025
Q3 		$10.1K Buy
+1,202
New +$8.13K ﹤0.01% 2591

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Arax Advisory Partners's TNGX Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 1,218 shares worth $38.1K. The stake represents ﹤0.01% of the portfolio and ranks #3495 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in TNGX as recently as Q4 2025.

Arax Advisory Partners first reported a position in TNGX in Q3 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Arax Advisory Partners held 1,218 shares of Tango Therapeutics worth $38.1K as of Q2 2026.
  • Tango Therapeutics was a new Arax Advisory Partners position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3495 holding.
  • Arax Advisory Partners first reported a position in Tango Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.